神經回饋市場規模、佔有率和成長分析：按產品、模式（基於模式的神經回饋）、應用、最終用戶、年齡層和地區分類－2026-2033年產業預測

2024 年全球神經回饋市場價值為 1.289 億美元，預計到 2033 年將成長至 2.3299 億美元，而 2025 年為 1.3767 億美元，預測期（2026-2033 年）的複合年成長率為 6.8%。

全球神經回饋市場的主要驅動力是人們對非藥物心理健康治療日益成長的需求。神經回饋透過將腦電波活動轉化為即時回饋，幫助個體自我調節神經模式，從而避免對藥物的依賴。焦慮症、注意力不足過動症（ADHD）和創傷後壓力症候群（PTSD）的盛行率不斷上升，促使臨床醫師探索實證替代療法，進而推動醫院和保險公司增加對神經調控研究的投入。成功的試驗研究凸顯了神經回饋的有效性，其納入醫保範圍的臨床服務正在推動全球醫療保健系統的顯著成長。穿戴式腦電圖（EEG）技術和雲端分析的融合有望徹底改變市場格局，使神經回饋更加普及。與保險公司的合作正在進一步加速市場滲透，吸引投資，並拓展神經反饋在各個領域最佳化績效的應用。

全球神經回饋市場的成長要素

全球神經回饋市場正顯著擴張，這主要得益於人們對非藥物療法的日益青睞。這是因為醫療服務提供者正在積極尋求替代療法，以最大限度地減少藥物治療的副作用，同時優先考慮以患者為中心的護理。神經回饋是一種非侵入性的腦功能調節技術，能夠有效輔助控制各種神經和精神疾病的相關症狀。這種方法是對綜合治療策略的補充，並正被包括醫院、復健中心和門診診所在內的各種醫療機構所接受。因此，對神經回饋設備、軟體解決方案、專業培訓以及持續研究的需求持續旺盛，這些研究旨在驗證其臨床療效。

全球神經回饋市場面臨的限制因素

神經回饋服務缺乏標準化的保險報銷政策，極大地限制了其在臨床實踐中的應用。由於許多保險公司將神經反饋歸類為“實驗性”或“輔助療法”，醫療服務提供者在成本回收方面常常面臨不確定性。這導致保險覆蓋範圍有限，患者自費增加。這造成了巨大的經濟障礙，阻礙了醫療專業人員投資必要的設備和培訓。這些障礙限制了患者獲得神經回饋的機會，阻礙了其融入常規治療方案，並最終抑制了市場成長，儘管臨床上對此越來越感興趣。因此，醫療服務提供者往往更傾向於選擇保險報銷方案更明確的療法，這進一步限制了神經反饋的市場滲透率。

全球神經回饋市場趨勢

隨著消費者日益重視心理健康，全球神經回饋市場正經歷著向個人化居家解決方案的顯著轉變。這種需求的激增推動了攜帶式神經反饋設備的研發，使用戶能夠在舒適的家中接受經臨床檢驗的訓練。製造商致力於打造無縫體驗，透過使用者友善的耳機、引導式軟體和訂閱式內容等創新方式，最大限度地減少用戶前往醫療機構的次數。這一趨勢不僅幫助個人主動管理壓力、提升專注力和改善睡眠，還將市場拓展到傳統臨床環境之外，增強了品牌忠誠度，並為醫療服務提供者創造了新的收入來源。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球神經回饋市場規模：按產品類別分類

• 神經回饋系統
• 神經回饋軟體
• 配件和耗材

全球神經回饋市場規模：按模式分類

• 基於腦電圖（EEG）的神經回饋
• 基於功能性磁振造影（fMRI）的神經回饋
• 基於腦血流圖（HEG）的神經回饋
• 其他

全球神經回饋市場規模：按應用領域分類

• 注意力不足過動症（ADHD）
• 焦慮和壓力障礙
• 憂鬱症
• 失眠和睡眠障礙
• 癲癇
• 認知功能和巔峰表現的提升
• 其他

全球神經回饋市場規模：按最終用戶分類

• 醫院
• 專科診所及神經治療中心
• 研究和學術機構
• 居家醫療

全球神經回饋市場規模：依年齡層別分類

• 兒童
• 成人
• 老年人

全球神經回饋市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• BrainMaster Technologies Inc
• Braintronics BV
• Thought Technology Ltd
• Mind Media USA Inc
• Neurobit Inc
• Wearable Sensing
• Emotiv Inc
• Neurosky
• Starlab Barcelona SL
• ANT Neuro
• Compumedics Limited
• Natus Medical Incorporated
• g tec medical engineering GmbH
• NeuroNexus Technologies Inc
• Bio-Medical Instruments Inc
• Cognionics Inc
• Interaxon Inc
• Myndlift
• Nexus Bio
• EEGer

結論與建議

Global Neurofeedback Market size was valued at USD 128.9 Million in 2024 and is poised to grow from USD 137.67 Million in 2025 to USD 232.99 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global neurofeedback market is primarily driven by the increasing demand for non-pharmacological mental health therapies. By translating brain-wave activity into real-time feedback, neurofeedback allows individuals to self-regulate neural patterns, avoiding medication reliance. Rising prevalence of anxiety, ADHD, and PTSD has led clinicians to seek evidence-based alternatives, resulting in increased funding for neuromodulation research from hospitals and insurers. Successful pilot studies have highlighted the effectiveness of neurofeedback, transitioning it into a reimbursable clinical service and fostering significant growth in health systems globally. The integration of wearable EEG technology with cloud analytics is set to revolutionize the market, making neurofeedback more accessible. Collaborative efforts with insurers are further accelerating market penetration, attracting investment and expanding applications into performance optimization for various demographics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurofeedback market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurofeedback Market Segments Analysis

Global neurofeedback market is segmented by product, modality, application, end user, age group and region. Based on product, the market is segmented into neurofeedback systems, neurofeedback software and accessories & consumables. Based on modality, the market is segmented into electroencephalography (EEG)-based neurofeedback, functional magnetic resonance imaging (fMRI)-based neurofeedback, hemoencephalography (HEG)-based neurofeedback and others. Based on application, the market is segmented into attention deficit hyperactivity disorder (ADHD), anxiety & stress disorders, depression, insomnia & sleep disorders, epilepsy, cognitive enhancement & peak performance and others. Based on end user, the market is segmented into hospitals, specialty clinics & neurotherapy centers, research & academic institutions and home care settings. Based on age group, the market is segmented into pediatric, adult and geriatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurofeedback Market

The expansion of the Global Neurofeedback market is significantly influenced by an increasing preference for non-pharmacological treatments, as healthcare providers actively look for alternatives that minimize medication-related side effects while emphasizing patient-centered care. Neurofeedback presents a non-invasive technique for regulating brain function, effectively assisting in the management of symptoms associated with various neurological and psychiatric disorders. This approach complements comprehensive treatment strategies, facilitating greater acceptance in diverse healthcare settings such as hospitals, rehabilitation facilities, and outpatient clinics. As a result, there is a persistent demand for neurofeedback equipment, software solutions, professional training, and continuous research efforts to confirm its clinical effectiveness.

Restraints in the Global Neurofeedback Market

The lack of standardized reimbursement policies for neurofeedback services significantly limits widespread adoption in clinical settings. Healthcare providers often encounter ambiguity regarding cost recovery, as many insurance companies classify neurofeedback as either experimental or supplementary therapy. This results in minimal coverage and increased out-of-pocket costs for patients, creating a financial obstacle that deters practitioners from investing in necessary equipment and training. Such barriers restrict patient access to neurofeedback and hinder its integration into conventional treatment regimens, ultimately constraining market growth despite increasing clinical interest. As a result, providers frequently favor therapies with more definitive reimbursement options, further restricting neurofeedback's market reach.

Market Trends of the Global Neurofeedback Market

The Global Neurofeedback market is witnessing a significant trend toward personalized home solutions as consumers prioritize mental wellness. This surge in demand has led to the development of portable neurofeedback devices that allow for clinically-validated training within the comfort of one's home. Manufacturers are innovating with user-friendly headsets, guided software, and subscription-based content, aiming to create seamless experiences that minimize the need for clinical visits. This trend not only empowers individuals to manage their stress, focus, and sleep proactively but also expands the market beyond traditional clinical environments, fostering brand loyalty and generating new revenue streams for providers.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Neurofeedback Market Size by Product & CAGR (2026-2033)

• Market Overview
• Neurofeedback Systems
• Neurofeedback Software
• Accessories & Consumables

Global Neurofeedback Market Size by Modality & CAGR (2026-2033)

• Market Overview
• Electroencephalography (EEG)-Based Neurofeedback
• Functional Magnetic Resonance Imaging (fMRI)-Based Neurofeedback
• Hemoencephalography (HEG)-Based Neurofeedback
• Others

Global Neurofeedback Market Size by Application & CAGR (2026-2033)

• Market Overview
• Attention Deficit Hyperactivity Disorder (ADHD)
• Anxiety & Stress Disorders
• Depression
• Insomnia & Sleep Disorders
• Epilepsy
• Cognitive Enhancement & Peak Performance
• Others

Global Neurofeedback Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics & Neurotherapy Centers
• Research & Academic Institutions
• Home Care Settings

Global Neurofeedback Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Neurofeedback Market Size & CAGR (2026-2033)

• North America (Product, Modality, Application, End User, Age Group)
  • US
  • Canada
• Europe (Product, Modality, Application, End User, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Modality, Application, End User, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Modality, Application, End User, Age Group)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Modality, Application, End User, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BrainMaster Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braintronics BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thought Technology Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mind Media USA Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurobit Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wearable Sensing
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emotiv Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurosky
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Starlab Barcelona SL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANT Neuro
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• g tec medical engineering GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroNexus Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Medical Instruments Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognionics Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Interaxon Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myndlift
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexus Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EEGer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations